Paloma Partners Management Co - SEATTLE GENETICS INC ownership

SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 332 filers reported holding SEATTLE GENETICS INC in Q3 2018. The put-call ratio across all filers is 0.53 and the average weighting 0.2%.

Quarter-by-quarter ownership
Paloma Partners Management Co ownership history of SEATTLE GENETICS INC
ValueSharesWeighting
Q3 2020$366,000
-85.6%
1,868
-87.5%
0.01%
-79.5%
Q2 2020$2,541,000
+489.6%
14,953
+140.2%
0.04%
+528.6%
Q2 2019$431,000
-89.1%
6,224
-88.5%
0.01%
-92.7%
Q1 2019$3,971,000
+147.6%
54,222
+160.8%
0.10%
+231.0%
Q3 2018$1,604,000
-7.2%
20,790
-20.1%
0.03%
-9.4%
Q2 2018$1,728,000
+114.4%
26,018
+69.0%
0.03%
+146.2%
Q1 2018$806,000
+14.5%
15,399
+17.2%
0.01%
+44.4%
Q4 2017$704,000
-58.8%
13,143
-60.2%
0.01%
-55.0%
Q2 2017$1,707,000
+28.4%
32,991
+56.1%
0.02%
+25.0%
Q1 2017$1,329,000
+89.3%
21,139
+59.1%
0.02%
+128.6%
Q4 2016$702,000
-51.7%
13,287
-50.6%
0.01%
-61.1%
Q3 2016$1,453,000
+62.5%
26,900
+21.5%
0.02%
+80.0%
Q2 2016$894,000
-27.6%
22,133
-19.5%
0.01%
-69.7%
Q4 2015$1,235,000
-70.6%
27,507
-68.3%
0.03%
-59.3%
Q2 2015$4,196,000
+595.9%
86,700
+408.6%
0.08%
+376.5%
Q1 2015$603,000
-16.0%
17,047
-11.7%
0.02%
-48.5%
Q3 2014$718,000
+223.4%
19,304
+232.8%
0.03%
+266.7%
Q2 2014$222,000
-2.6%
5,800
+16.1%
0.01%
-40.0%
Q1 2014$228,000
-96.8%
4,995
-97.8%
0.02%
-96.2%
Q2 2013$7,023,000223,2220.39%
Other shareholders
SEATTLE GENETICS INC shareholders Q3 2018
NameSharesValueWeighting ↓
Baker Brothers Advisors 45,725,556$2,365,840,00020.68%
Lagoda Investment Management, L.P. 398,529$20,620,0007.88%
Matrix Capital Management Company, LP 2,118,000$109,585,0003.72%
Ghost Tree Capital, LLC 300,000$15,522,0003.23%
Sio Capital Management, LLC 100,000$5,174,0002.46%
GREAT POINT PARTNERS LLC 249,500$12,909,0002.31%
Redmile Group, LLC 665,139$34,414,0002.10%
Eventide Asset Management 525,000$27,164,0001.69%
Opus Point Partners Management, LLC 35,093$1,816,0001.66%
Boxer Capital, LLC 125,000$6,468,0001.54%
View complete list of SEATTLE GENETICS INC shareholders